Transparency good bye - u-turn of EMA concerning drug trial data

Insulin degludec (TRESIBA) for diabetes mellitus

Tick-borne encephalitis (II)

Ivabradine (PROCOROLAN) - increase of cardiovascular complications in patients with angina pectoris

Risk-benefit assessment of ambroxol (MUCOSOLVAN, generics) and bromhexin (BISOLVON, generics)

US poison centers - red flag about electronic cigarettes

Now after all: early benefit assessment of dimethyl fumarate

Warning about Miracle Mineral Supplement (MMS) miracle cure

ROLENIUM ELPENHALER (fluticasone propionate + salmeterol): use prone to errors

Quetiapin (SEROQUEL, generics) - acute liver failure and ischemic colitis

Aspirin without benefit for primary prevention of heart attack and stroke

© arznei-telegramm 6/2014